Grant: Master's Award: Canada Graduate Scholarships
Université de Montréal
$17,500.00
The Human DDX3X Helicase as an Antiviral Target for HSV-1 Replication
FY 2021-22
Summary
It is believed that the herpes simplex virus 1 (HSV-1) is present in almost 90% of the world population. HSV-1 lies dormant in most carriers, but complications in patients with clinical symptoms can sometimes lead to death. As in many other viruses, HSV-1 interacts with a multitude of cellular partners to hijack the hosts cell machinery. Some of these partners may be incorporated into new viral particles. The inclusion of these cellular proteins often facilitates one or more of the stages of the replication cycle. With respect to HSV-1, analysis of extracellular virions revealed that ;DDX3X is one of these cellular proteins. DDX3X is an ATP-dependent RNA helicase that modulates several stages of gene expression in human cells. By inhibiting the expression of DDX3X with siRNAs in the context of a HSV-1 infection, this enzyme was shown to participate in the replication cycle by promoting transcription of viral genes. However, other results revealed an additional and unexpected function for a helicase. Indeed, it was discovered that DDX3X interacts with pUL31, a viral protein involved in the budding of capsids outside the nucleus. In addition, inhibition of DDX3X hampered the normal transport of fully assembled viral particles. These results suggest that DDX3X has a proviral role beyond transcription by participating in the nucleus exit process and allowing the release of viral particles into extracellular space. However, the mechanism of action of DDX3X and the extent of DDX3X helicase enzyme activity remain to be defined. Furthermore, various other viruses have been shown to require this helicase during replication. DDX3X is therefore a very interesting target for the creation of broad-spectrum antivirals.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
466545
Name
Licea Jonas
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The Human DDX3X Helicase as an Antiviral Target for HSV-1 Replication
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antivirals; Cellular Mechanisms; Ddx3x; Enzymatic Activity; Helicase; Hsv-1; Nuclear Egress; Viral Budding; Viral Replication; Virus
Abstract
It is believed that the herpes simplex virus 1 (HSV-1) is present in almost 90% of the world population. HSV-1 lies dormant in most carriers, but complications in patients with clinical symptoms can sometimes lead to death. As in many other viruses, HSV-1 interacts with a multitude of cellular partners to hijack the hosts cell machinery. Some of these partners may be incorporated into new viral particles. The inclusion of these cellular proteins often facilitates one or more of the stages of the replication cycle. With respect to HSV-1, analysis of extracellular virions revealed that ;DDX3X is one of these cellular proteins. DDX3X is an ATP-dependent RNA helicase that modulates several stages of gene expression in human cells. By inhibiting the expression of DDX3X with siRNAs in the context of a HSV-1 infection, this enzyme was shown to participate in the replication cycle by promoting transcription of viral genes. However, other results revealed an additional and unexpected function for a helicase. Indeed, it was discovered that DDX3X interacts with pUL31, a viral protein involved in the budding of capsids outside the nucleus. In addition, inhibition of DDX3X hampered the normal transport of fully assembled viral particles. These results suggest that DDX3X has a proviral role beyond transcription by participating in the nucleus exit process and allowing the release of viral particles into extracellular space. However, the mechanism of action of DDX3X and the extent of DDX3X helicase enzyme activity remain to be defined. Furthermore, various other viruses have been shown to require this helicase during replication. DDX3X is therefore a very interesting target for the creation of broad-spectrum antivirals.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Licea, Jonas
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~